378 related articles for article (PubMed ID: 29988365)
1. Sex Differences in Autophagy Contribute to Female Vulnerability in Alzheimer's Disease.
Congdon EE
Front Neurosci; 2018; 12():372. PubMed ID: 29988365
[TBL] [Abstract][Full Text] [Related]
2. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
[TBL] [Abstract][Full Text] [Related]
3. The Implications of Autophagy in Alzheimer's Disease.
Hamano T; Hayashi K; Shirafuji N; Nakamoto Y
Curr Alzheimer Res; 2018; 15(14):1283-1296. PubMed ID: 30289076
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
6. Targeting Autophagy for the Treatment of Alzheimer's Disease: Challenges and Opportunities.
Liu J; Li L
Front Mol Neurosci; 2019; 12():203. PubMed ID: 31507373
[TBL] [Abstract][Full Text] [Related]
7. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
8. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
9. Selenium-enriched yeast inhibited β-amyloid production and modulated autophagy in a triple transgenic mouse model of Alzheimer's disease.
Song GL; Chen C; Wu QY; Zhang ZH; Zheng R; Chen Y; Jia SZ; Ni JZ
Metallomics; 2018 Aug; 10(8):1107-1115. PubMed ID: 30043821
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Autophagy as a Therapeutic Target for Alzheimer's Disease.
Steele JW; Fan E; Kelahmetoglu Y; Tian Y; Bustos V
Postdoc J; 2013 Feb; 1(2):21-34. PubMed ID: 28286801
[TBL] [Abstract][Full Text] [Related]
11. Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications.
Uddin MS; Stachowiak A; Mamun AA; Tzvetkov NT; Takeda S; Atanasov AG; Bergantin LB; Abdel-Daim MM; Stankiewicz AM
Front Aging Neurosci; 2018; 10():04. PubMed ID: 29441009
[TBL] [Abstract][Full Text] [Related]
12. Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis.
Uddin MS; Mamun AA; Labu ZK; Hidalgo-Lanussa O; Barreto GE; Ashraf GM
J Cell Physiol; 2019 Jun; 234(6):8094-8112. PubMed ID: 30362531
[TBL] [Abstract][Full Text] [Related]
13. Trilateral association of autophagy, mTOR and Alzheimer's disease: Potential pathway in the development for Alzheimer's disease therapy.
Subramanian A; Tamilanban T; Alsayari A; Ramachawolran G; Wong LS; Sekar M; Gan SH; Subramaniyan V; Chinni SV; Izzati Mat Rani NN; Suryadevara N; Wahab S
Front Pharmacol; 2022; 13():1094351. PubMed ID: 36618946
[TBL] [Abstract][Full Text] [Related]
14. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
15. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
16. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
17. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
18. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
Thal DR; Attems J; Ewers M
J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
[TBL] [Abstract][Full Text] [Related]
19. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.
Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G
Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887
[TBL] [Abstract][Full Text] [Related]
20. Accelerated Ovarian Failure as a Unique Model to Study Peri-Menopause Influence on Alzheimer's Disease.
Marongiu R
Front Aging Neurosci; 2019; 11():242. PubMed ID: 31551757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
